Klaudia Lucius, E. Simińska
{"title":"Mechanizmy ustalania cen produktów na rynku farmaceutycznym","authors":"Klaudia Lucius, E. Simińska","doi":"10.14595/PES/02/023","DOIUrl":null,"url":null,"abstract":"The pharmaceutical market is characterized by the existence of state regulations restricting his freedom to market and is one of the fastest growing sectors of the economy all over the world. Factors that have a real impact on determining the price of drugs can be grouped into three categories: medical factors, economic factors, political and environmental factors. In the group of medical factors can be distinguished patent protection, the cost of producing the drug and the value of the drug. To economic factors, taking into account the aspect of market competitiveness of companies, include: the size of the producer, nature of the company - whether it is a research unit of the pharmaceutical company, return on investment – effectiveness of use of expenditure with the aim of achieving a profit (return on investment, ROI), profitability entity. The remaining group of factors (environmental, and political) relate mainly to national regulations. They are connected with among others the registration system of marketing authorization, whether a reimbursement system that determines whether and how drugs are financed from public funds. Membership in the European Union forces on all Member States to make reimbursement decisions by the so-called Transparency Directive. It is connected with the obligation to justify decisions, and calling upon objective reasons. Medical Technology Assessment Agency formulating recommendations take into account factors i.e. a therapeutic, benefits for the patients, cost-effectiveness, impact on the budget.","PeriodicalId":243710,"journal":{"name":"Progress in Economic Sciences","volume":"27 2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2015-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Economic Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14595/PES/02/023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

医药市场的特点是存在国家规定,限制其自由进入市场,是世界上增长最快的经济部门之一。对确定药品价格有实际影响的因素可分为三类:医疗因素、经济因素、政治因素和环境因素。在这组医学因素中可以区分专利保护、药品的生产成本和药品的价值。要考虑经济因素,公司的市场竞争力方面,包括:生产商的规模、公司的性质——是否是制药公司的研究单位、投资回报率——以实现利润为目的的支出使用的有效性(投资回报率,ROI)、实体的盈利能力。剩下的一组因素(环境和政治)主要与国家法规有关。除其他外,它们与上市许可的注册制度有关,是否报销制度决定了药物是否以及如何从公共资金中获得资金。欧洲联盟的成员资格迫使所有成员国根据所谓的透明度指令作出偿还决定。它与为决定辩护的义务和要求客观理由有关。医疗技术评估机构在制定建议时考虑到以下因素:治疗、对患者的益处、成本效益、对预算的影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Mechanizmy ustalania cen produktów na rynku farmaceutycznym
The pharmaceutical market is characterized by the existence of state regulations restricting his freedom to market and is one of the fastest growing sectors of the economy all over the world. Factors that have a real impact on determining the price of drugs can be grouped into three categories: medical factors, economic factors, political and environmental factors. In the group of medical factors can be distinguished patent protection, the cost of producing the drug and the value of the drug. To economic factors, taking into account the aspect of market competitiveness of companies, include: the size of the producer, nature of the company - whether it is a research unit of the pharmaceutical company, return on investment – effectiveness of use of expenditure with the aim of achieving a profit (return on investment, ROI), profitability entity. The remaining group of factors (environmental, and political) relate mainly to national regulations. They are connected with among others the registration system of marketing authorization, whether a reimbursement system that determines whether and how drugs are financed from public funds. Membership in the European Union forces on all Member States to make reimbursement decisions by the so-called Transparency Directive. It is connected with the obligation to justify decisions, and calling upon objective reasons. Medical Technology Assessment Agency formulating recommendations take into account factors i.e. a therapeutic, benefits for the patients, cost-effectiveness, impact on the budget.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信